标题
Radioimmunotherapy for hematopoietic cell transplantation
作者
关键词
-
出版物
Immunotherapy
Volume 5, Issue 4, Pages 383-394
出版商
Future Medicine Ltd
发表日期
2013-04-04
DOI
10.2217/imt.13.11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results
- (2012) I. F. Khouri et al. BLOOD
- Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma
- (2012) W A Bethge et al. BONE MARROW TRANSPLANTATION
- A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma
- (2012) Avichai Shimoni et al. CANCER
- Matched-Cohort Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy versus Total Body Irradiation–Based Conditioning for Poor-Risk Diffuse Large Cell Lymphoma
- (2011) Amrita Krishnan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model
- (2011) J. M. Pagel et al. BLOOD
- Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases
- (2011) A. S. Schulz et al. BLOOD
- Durable donor engraftment after radioimmunotherapy using -emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation
- (2011) Y. Chen et al. BLOOD
- 90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma
- (2011) A. K. Gopal et al. BLOOD
- 90 Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma
- (2011) K E Abou-Nassar et al. BONE MARROW TRANSPLANTATION
- Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
- (2011) S. I. Park et al. CLINICAL CANCER RESEARCH
- 90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study
- (2011) Didier Decaudin et al. Clinical Lymphoma Myeloma & Leukemia
- Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study
- (2010) W. A. Bethge et al. BLOOD
- Sequential Cytarabine and -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
- (2010) T. L. Rosenblat et al. CLINICAL CANCER RESEARCH
- Pilot Study of a 213Bismuth-Labeled Anti-CD45 mAb as a Novel Nonmyeloablative Conditioning for DLA-Haploidentical Littermate Hematopoietic Transplantation
- (2010) Hirohisa Nakamae et al. TRANSPLANTATION
- Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2009) J. M. Pagel et al. BLOOD
- Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
- (2009) D. J. Green et al. BLOOD
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
- (2009) John Koreth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
- (2009) Jane N. Winter et al. JOURNAL OF CLINICAL ONCOLOGY
- Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia
- (2008) Christian Koenecke et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More